Dyslipidaemia and its treatment in patients with type 2 diabetes: A joint analysis of the German DIVE and DPV registries-Reference-Cited by-同舟云学术

Dyslipidaemia and its treatment in patients with type 2 diabetes: A joint analysis of the German DIVE and DPV registries

Published:2016-09-29 Issue:1 Volume:19 Page:61-69
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Bramlage Peter¹,Lanzinger Stefanie²³,Rathmann Wolfgang⁴,Gillessen Anton⁵,Scheper Nikolaus⁶,Schmid Sebastian M.⁷⁸,Kaltheuner Matthias⁹,Seufert Jochen¹⁰,Danne Thomas¹¹,Holl Reinhard W.²³

Affiliation:

1. Institute for Pharmacology and Preventative Medicine; Mahlow Germany

2. ZIBMT, Institute of Epidemiology and Medical Biometry; University of Ulm; Ulm Germany

3. Deutsches Diabetes Zentrum; München-Neuherberg Germany

4. Institute of Biometry and Epidemiology; Deutsches Diabetes Zentrum; Düsseldorf Germany

5. Herz-Jesu-Krankenhaus Münster; Münster Germany

6. Diabetesschwerpunktpraxis; Marl Germany

7. Medizinische Klinik 1, Universitätsklinikum Schleswig-Holstein; Lübeck Germany

8. Deutsches Diabetes Zentrum; Lübeck Germany

9. Diabetesschwerpunktpraxis; Leverkusen Germany

10. Department of Internal Medicine; Universitätsklinikum Freiburg; Freiburg Germany

11. Diabeteszentrum für Kinder und Jugendliche; Kinderkrankenhaus auf der Bult; Hannover Germany

Funder

European Foundation for the Study of Diabetes

German Competence Network Diabetes

Bundesministerium für Bildung und Forschung

German Centre for Diabetes Research (DZD)

Sanofi Aventis Deutschland GmbH

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12783/fullpdf

Reference41 articles.

1. Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications;Bardini;Rev Diabet Stud,2012

2. Lipids and lipoproteins in patients with type 2 diabetes;Krauss;Diabetes Care,2004

3. New insights into the pathophysiology of dyslipidemia in type 2 diabetes;Taskinen;Atherosclerosis,2015

4. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease;Toth;Vasc Health Risk Manag,2016

5. Triglycerides and triglyceride-rich lipoproteins in the causal pathway of cardiovascular disease;Budoff;Am J Cardiol,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in cardiovascular risk factors among children and young adults with type 1 diabetes during the COVID‐19 pandemic compared to previous years—Results from the German DPV registry;Journal of Diabetes;2023-01

2. DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus;BMJ Open Diabetes Research & Care;2021-06

3. National diabetes registries: do they make a difference?;Acta Diabetologica;2020-08-08

4. Renal function deterioration in adult patients with type-2 diabetes;BMC Nephrology;2020-07-29

5. Pattern of dyslipidaemia in relation to statin use in patients with type 2 diabetes mellitus attending a tertiary care hospital;Journal of Endocrinology, Metabolism and Diabetes of South Africa;2019-12-02